Nan Gonghua
In addition to the latest two new crown oral drugs, Sennuoxin and Mindevit, five new crown oral drugs have been approved for marketing in China. It’s just that it has only been approved for listing now, which really makes people lament that it is a bit late. No matter what the principle of the drug is, which stage or age group it is suitable for patients to take, these new crown special drugs should be prepared before the epidemic is released.
Now the most dangerous first wave of infection climax has passed. Although there will be more waves of infection in the future, the elderly and patients with underlying diseases who died in the first wave may have accounted for the majority of the total. For the new crown specific drug manufacturers In other words, it also missed the best sales opportunity for drugs.
This article is reproduced from: https://www.fortunechina.com/jingxuan/26371.htm
This site is only for collection, and the copyright belongs to the original author.